Catálogo Taxonômico da Fauna do Brasil: setting the baseline knowledge on the animal diversity in Brazil

The limited temporal completeness and taxonomic accuracy of species lists, made available in a traditional manner in scientific publications, has always represented a problem. These lists are invariably limited to a few taxonomic groups and do not represent up-to-date knowledge of all species and classifications. In this context, the Brazilian megadiverse fauna is no exception, and the Catálogo Taxonômico da Fauna do Brasil (CTFB) (http://fauna.jbrj.gov.br/), made public in 2015, represents a database on biodiversity anchored on a list of valid and expertly recognized scientific names of animals in Brazil. The CTFB is updated in near real time by a team of more than 800 specialists. By January 1, 2024, the CTFB compiled 133,691 nominal species, with 125,138 that were considered valid. Most of the valid species were arthropods (82.3%, with more than 102,000 species) and chordates (7.69%, with over 11,000 species). These taxa were followed by a cluster composed of Mollusca (3,567 species), Platyhelminthes (2,292 species), Annelida (1,833 species), and Nematoda (1,447 species). All remaining groups had less than 1,000 species reported in Brazil, with Cnidaria (831 species), Porifera (628 species), Rotifera (606 species), and Bryozoa (520 species) representing those with more than 500 species. Analysis of the CTFB database can facilitate and direct efforts towards the discovery of new species in Brazil, but it is also fundamental in providing the best available list of valid nominal species to users, including those in science, health, conservation efforts, and any initiative involving animals. The importance of the CTFB is evidenced by the elevated number of citations in the scientific literature in diverse areas of biology, law, anthropology, education, forensic science, and veterinary science, among others

Impacto da COVID-19 em doenças de notificação compulsória no Norte do Brasil

Objetivo: Avaliar o impacto da pandemia COVID-19 em doenças de notificação compulsória no Norte do Brasil. Métodos: Estudo descritivo e retrospectivo realizado com dados das bases Sinan (Sistema de Informação de Agravos de Notificação) e SIH/SUS (Sistema de Informações Hospitalares do SUS) sobre meningite bacteriana e viral, dengue, febre hemorrágica da dengue, arboviroses, sífilis, tuberculose, hanseníase e hepatites virais. Utilizou-se estatística descritiva para avaliação da variação nos números absolutos das notificações e internações do período de 2015 a 2020 e suas variações médias. Resultados: As notificações e internações de meningite, arboviroses não-dengue, hanseníase, leptospirose e hepatites virais, em geral, demonstraram redução de 50 até 80% em relação a períodos anteriores. Houve variabilidade regional com dengue e febre hemorrágica da dengue, com aumentos e reduções independentes. As sífilis adquirida, gestacional e congênita demonstraram queda de até 60% nas notificações e nas internações, exceto sífilis congênita, que se manteve em estabilidade. As notificações e as internações de tuberculose se mantiveram estáveis em toda a região. Conclusão: Houve redução geral de mais da metade das notificações e das internações hospitalares, apresentando um impacto variável, dependendo do Estado e do processo deendemia de cada sub-região

Robotic‐assisted approaches to urachal carcinoma: A comprehensive systematic review of the safety and efficacy outcomes

Abstract Introduction Surgical intervention is the treatment of choice in patients with urachal carcinoma. Due to complications and to reduce hospital stay from open surgery, minimally invasive approaches are desirable. Nowadays, robotic‐assisted surgery has become increasingly popular, and robot‐assisted cystectomy can be performed in patients with urachal carcinoma with low complication rates. Methods We performed a systematic review to search for studies that evaluated patients who underwent robotic‐assisted surgery for urachal carcinoma. The outcomes of interest were the type of cystectomy performed, whether there was umbilicus resection, total operative time, console time, intraoperative complications, estimated blood loss, postoperative complications, time of hospitalisation, positive surgical margins and the presence of documented tumour recurrence. Results In this study, we evaluated three cohorts comprising a total of 21 patients. The median follow‐up period ranged from 8 to 40 months. Medium age was between 51 and 54 years, with a majority (63.1%) being male. One patient (5.2%) underwent a radical cystectomy, and 19 patients (94.7%) underwent to partial cystectomy. Umbilical resections were performed in all cases, and pelvic lymphadenectomy in 14 cases (73.6%). Recurrence occurred in three patients at a median of 17 months postoperation, two cases in the trocar insertion site. Additionally, there was one death, which was attributed to postoperative cardiovascular complications. Conclusion Robotic‐assisted partial cystectomy has a low incidence of adverse outcomes in patients with urachal carcinoma. Controlled studies, ideally randomised, are warranted to establish the comparative efficacy and safety of the robotic‐assisted cystectomy approach relative to open surgery